Results 231 to 240 of about 1,442,988 (353)

In vitro and in vivo properties of a dimeric bispecific single‐chain antibody IgG‐fusion protein for depletion of CCR2+ target cells in mice

open access: bronze, 2005
Martin Schneider   +6 more
openalex   +1 more source

Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti‐di‐diethylenetriaminepentaacetic acid F(ab′)2 antibody [PDF]

open access: bronze, 2010
Frits Aarts   +8 more
openalex   +1 more source

Belantamab Mafodotin Monotherapy for Multiply‐Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland

open access: yeseJHaem, Volume 6, Issue 3, June 2025.
ABSTRACT Introduction Belantamab mafodotin (belamaf) was the first BCMA‐targeting immunotherapy licensed in myeloma and was available as monotherapy for a fifth or greater line of treatment. Outcomes for patients in the United Kingdom and the Republic of Ireland potentially differ from those of other regions and may illuminate factors predicting ...
Edmund C. R. Watson   +26 more
wiley   +1 more source

Nuclear Imaging of Bispecific Antibodies on the Rise. [PDF]

open access: yesJ Nucl Med
Roohani B   +4 more
europepmc   +1 more source

Characteristic, Regulation and Targeting Strategies of Cancer Stem Cells and Their Niche in Digestive System Tumors

open access: yesMedComm – Oncology, Volume 4, Issue 2, June 2025.
Cancer stem cells, characterized by self‐renewal, differentiation, heterogeneity, plasticity and tumorigenicity, are regulated by intrinsic factors such as signaling pathways, transcription factors, metabolism and noncoding RNAs, as well as environmental cells (including tumor cells, immune cells and stromal cells), environmental factors and distant ...
Zhenzhen Chen   +11 more
wiley   +1 more source

Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T Cells [PDF]

open access: green, 2011
Hitoe Torisu‐Itakura   +7 more
openalex   +1 more source

Netrin‐1 and B‐cell maturation antigen expression in a large cohort of 361 lymphomas: sensitive and specific staining in plasmablastic lymphomas, and therapeutic perspectives

open access: yesThe Journal of Pathology: Clinical Research, Volume 11, Issue 3, May 2025.
Abstract Netrin‐1 and B‐cell maturation antigen (BCMA) are currently being evaluated as therapeutic targets in oncology. However, studies investigating their expression in mature human lymphoid malignancies are sparse. This study aimed to investigate the expression of BCMA and Netrin‐1 in a large cohort of lymphomas to determine their potential role as
Marie Donzel   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy